Previous close | 6.20 |
Open | 5.96 |
Bid | 5.90 |
Ask | 6.20 |
Strike | 50.00 |
Expiry date | 2024-05-17 |
Day's range | 5.96 - 6.15 |
Contract range | N/A |
Volume | |
Open interest | 221 |
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....
It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...